Medicortex raises EUR 140k via Invesdor
Medicortex, a Turku, Finland medical company developing a rapid diagnostic test for detection of traumatic brain injury, closed an investment round totalling EUR 136,544 ($155k) on Invesdor. The financing round, started in March 2017, came from 83 investors which oversubscribed a EUR 120k initial target.
Medicortex, established in 2014 by CEO Adrian Harel, has under development a solution for the individuals who have suffered traumatic brain injury to be better aware of the condition and manage the situation. Once the development of the diagnostic kit is complete, the next goal is to expand the program to the development of innovative drug to halt the progression of brain injury.